Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

SHR

Schering Aktiengesel (SHR)

Bank of America Corp. Strategic Accelerated Redemption Securities Linked TO The S&P 500 Index
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:SHR
DateTimeSourceHeadlineSymbolCompany
01/19/20073:20AMPR Newswire (US)Bayer Schering Pharma to Develop New Imaging Compounds for Detection of Neurodegenerative DiseasesNYSE:SHRBank of America Corp. Strategic Accelerated Redemption Securities Linked TO The S&P 500 Index
12/05/20068:25AMPR Newswire (US)Bayer Determines EUR 98.98 as Cash Compensation per Schering ShareNYSE:SHRBank of America Corp. Strategic Accelerated Redemption Securities Linked TO The S&P 500 Index
11/28/20063:45AMPR Newswire (US)Schering AG and Stanford University to Cooperate in the Field of Molecular ImagingNYSE:SHR
11/27/20062:33AMPR Newswire (US)Schering AG Maintains Strong Growth Momentum During First Nine Months of 2006NYSE:SHR
11/24/200612:25PMPR Newswire (US)NYSE Suspends Trading in Schering ADRsNYSE:SHRBank of America Corp. Strategic Accelerated Redemption Securities Linked TO The S&P 500 Index
11/23/20064:40AMPR Newswire (US)Betaferon(R) Approved in Australia for Earliest Stages of Multiple SclerosisNYSE:SHR
11/08/20061:54AMPR Newswire (US)Go-Ahead for Schering's Integration Into the Bayer GroupNYSE:SHRBank of America Corp. Strategic Accelerated Redemption Securities Linked TO The S&P 500 Index
10/31/20068:00AMPR Newswire (US)Berlex Oncology Evaluating Combination Therapy for Common Form of Non-Hodgkin's LymphomaNYSE:SHR
10/30/20062:10PMPR Newswire (US)Entry in the Commercial Register - Agreement Between Bayer and Schering in Force - Resolution of Schering Extraordinary StockholNYSE:SHRBank of America Corp. Strategic Accelerated Redemption Securities Linked TO The S&P 500 Index
10/23/200610:39AMPR Newswire (US)FDA Approves Betaseron(R) for Use After the First Event Suggestive of Multiple SclerosisNYSE:SHR
10/17/20069:47AMPR Newswire (US)Family Planning Programs in the Fight Against PovertyNYSE:SHR
10/05/20068:30AMPR Newswire (US)FDA Approves New Indication for YAZ(R) to Treat Emotional and Physical Symptoms of Premenstrual Dysphoric Disorder (PMDD)NYSE:SHR
09/19/20063:58AMPR Newswire (US)Schering AG and Organon to Continue Research in Male Fertility Control SeparatelyNYSE:SHR
09/18/200610:01AMPR Newswire (US)Schering AG Licenses SEGRA Compound for Ophthalmic Use to Bausch & LombNYSE:SHR
09/15/20064:32AMPR Newswire (US)Schering AG and AstraZeneca Form Strategic Alliance to Develop Novel Anti-Cancer DrugNYSE:SHR
09/14/200610:00AMPR Newswire (US)MEDRAD Employees Care in a Big Way: Facilities Suspend Operations Today so That 800 Can Volunteer in CommunityNYSE:SHR
09/14/20068:48AMPR Newswire (US)Stockholders Pave the Way for Bayer Schering PharmaNYSE:SHR
09/13/20066:32AMPR Newswire (US)Extraordinary Stockholders' Meeting of Schering AG in BerlinNYSE:SHRBank of America Corp. Strategic Accelerated Redemption Securities Linked TO The S&P 500 Index
09/04/20067:19AMPR Newswire (US)Schering AG Completes Reconstruction Projects in Indonesia and ThailandNYSE:SHR
09/01/200610:00AMPR Newswire (US)MEDRAD Holds Job Fair To Support Company GrowthNYSE:SHRBank of America Corp. Strategic Accelerated Redemption Securities Linked TO The S&P 500 Index
08/30/20066:13AMPR Newswire (US)Group Environmental Report for 2006 PublishedNYSE:SHR
08/16/200611:50AMPR Newswire (US)Frost & Sullivan Lauds MEDRAD Excellent Product Innovation Abilities in the MRI Coils MarketNYSE:SHRBank of America Corp. Strategic Accelerated Redemption Securities Linked TO The S&P 500 Index
08/04/20064:15AMPR Newswire (US)Extraordinary Stockholders' Meeting of Schering AG on September 13, 2006: Schering's Stockholders to Resolve on Domination andNYSE:SHR
08/02/200610:00AMPR Newswire (US)New MEDRAD 3.0T Prostate eCoil(TM) Enables Personalized Treatment PlanningNYSE:SHR
07/31/200610:49AMPR Newswire (US)Berlex Voluntarily Recalls Ultravist(R) Injection 370 mgI/mLNYSE:SHR
07/31/200610:36AMPR Newswire (US)Schering AG, Germany Announces Results of Two Clinical Trials With Sargramostim in Crohn's Disease PatientsNYSE:SHR
07/31/200610:21AMPR Newswire (US)Schering Voluntarily Recalls Ultravist(R) Injection 370 mgI/mlNYSE:SHR
07/31/200610:20AMPR Newswire (US)Bayer Offer Remains Unchanged Despite Voluntary Ultravist(R) Injection 370 mgI/ml Recall and Insufficient Results of Clinical PNYSE:SHRBank of America Corp. Strategic Accelerated Redemption Securities Linked TO The S&P 500 Index
07/26/20062:46PMPR Newswire (US)KPMG Values Schering AG Share at EUR 87.63NYSE:SHR
07/25/20063:28AMPR Newswire (US)Schering AG Raises Outlook After Strong First Half YearNYSE:SHR
 Showing the most relevant articles for your search:NYSE:SHR